Based on this result, our study addressed the impact of ESR1 expression in the male GBM cohort to understand the reason for higher tumor aggressiveness in a subgroup of male patients compared to the rest of the males and all females with glioma. This evidence concerns the gene ESR1 and central nervous system cancer.